Cargando…
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
The etiological agent of coronavirus disease (COVID-19) is the new member of the Coronaviridae family, a severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2), responsible for the pandemic that is plaguing the world. The single-stranded RNA virus is capable of infecting the respiratory...
Autores principales: | Leão Batista Simões, Júlia, Fornari Basso, Helena, Cristine Kosvoski, Greicy, Gavioli, Jullye, Marafon, Filomena, Elias Assmann, Charles, Barbosa Carvalho, Fabiano, Dulce Bagatini, Margarete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435372/ https://www.ncbi.nlm.nih.gov/pubmed/34537482 http://dx.doi.org/10.1016/j.intimp.2021.108150 |
Ejemplares similares
-
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
por: dos Anjos, Fernanda, et al.
Publicado: (2020) -
Deregulation of purinergic ectoenzyme activity in head and neck cancer promotes immunosuppression
por: Marafon, Filomena, et al.
Publicado: (2022) -
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome
por: Simões, Júlia Leão Batista, et al.
Publicado: (2021) -
High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity
por: da Silva, Gilnei Bruno, et al.
Publicado: (2022) -
Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022)